alexa Fullerenol C60 As A New Therapeutic Nanomedicine For Inflammatory Bowel Disease
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Kazuma Higashisaka
Posters: Transl Med
DOI: 10.4172/2161-1025.S1.009
Abstract
Inflammatory bowel disease (IBD) is intractable disease that shows unexplained inflammation in the gastrointestinal tract. Although diverse therapeutic drugs such as 5-aminosalicylic acid (5-ASA) and N-acetyl-L-cysteine (NAC) were used, there were some problems with adverse effects and unresponsiveness. Therefore, it is expected to develop novel medicines. In this regard, we have focused on Fullerene C 60 , which is one of the most promising nanomaterials because of their antioxidant effect. We previously demonstrated that C 60 (OH) 36 , which is water-soluble fullerenol C 60 , have strong anti-oxidative and anti- inflammatory effects in vitro. Here, we evaluated the efficacy of C 60 (OH) 36 as a new therapeutic nanomedicine (~1 nm) for IBD. We examined the effects of C 60 (OH) 36 on IBD in animal model of dextran sulfate sodium (DSS). The DSS-induced colitis model has been extensively used because it shows similar symptoms compared to human colitis. Myeloperoxidase (MPO) activity is an index of acute inflammatory reaction with neutrophil infiltration into the colon. Therefore, we measured the levels of MPO activity in mice. MPO activity in C 60 (OH) 36 -treated and 5-ASA-treated mice were significantly decreased on the day 7 after DSS administration compared to that in distilled water-treated mice. These results indicated that C 60 (OH) 36 had a potential to be useful therapeutic nanomedicine for acute DSS experimental colitis. We expect that our studies might provide useful information for creating innovative nanomedicine for IBD.
Biography
Kazuma Higashisaka has completed his M.S. at the Graduate School of Pharmaceutical Sciences, Osaka University, Japan. His work was supervised by Professor Yasuo Tsutsumi, Ph.D. who is a specialist of nano-safety science/design/drug-delivery, and disease proteomics. Higashisaka is now working in Osaka University as Assistant Professor and studied the efficacy and toxicity of drugs and nanomaterials using ADMET approach. His works have already accepted and published in Biomaterials and it was selected as leading opinion paper. Additionally, the results of his works were presented at several congresses and one of his works had been prized a best poster award at SENN2012.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version